Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Floris J Pos

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patientsRuud C Wortel, Luca Incrocci, Floris J Pos, et al.
European Urology|March 27, 2016
The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer PatientsMarie-Anne van Stam, Neil K Aaronson, Floris J Pos, et al.
Journal of Cancer Survivorship : Research and Practice|May 10, 2020
Unmet expectations in prostate cancer patients and their association with decision regretBarbara M Wollersheim, Marie-Anne van Stam, Ruud J L H Bosch, et al.
Clinical and Translational Radiation Oncology|July 19, 2021
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancerCharlotte L Deijen, Gerbert L Vrijenhoek, Eva E Schaake, et al.
NMR in Biomedicine|July 6, 2018
Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancerEdzo M E Klawer, Petra J van Houdt, Floris J Pos, et al.
The Prostate|July 28, 2025
Efficacy of Treatments for T3bN0M0 Prostate Cancer Patients: A Systematic Review and Meta-AnalysisCasper Reijnen, Wilma D Heemsbergen, Kimberley E Wever, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Behavior of lipiodol markers during image guided radiotherapy of bladder cancerXiangfei Chai, Marcel van Herk, Jeroen B van de Kamer, et al.
Cancers|July 9, 2022
Specialist versus Primary Care Prostate Cancer Follow-Up: A Process Evaluation of a Randomized Controlled TrialBarbara M Wollersheim, Kristel M van Asselt, Floris J Pos, et al.
Clinical and Translational Radiation Oncology|January 7, 2025
Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancerChristian A M Jongen, Ben J M Heijmen, Wilco Schillemans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 2023
Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patientsMarie-Christina Jahreiß, Mischa Hoogeman, Katja Kh Aben, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patientsRuud C Wortel, Luca Incrocci, Floris J Pos, et al.
European Urology|March 27, 2016
The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer PatientsMarie-Anne van Stam, Neil K Aaronson, Floris J Pos, et al.
Journal of Cancer Survivorship : Research and Practice|May 10, 2020
Unmet expectations in prostate cancer patients and their association with decision regretBarbara M Wollersheim, Marie-Anne van Stam, Ruud J L H Bosch, et al.
Clinical and Translational Radiation Oncology|July 19, 2021
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancerCharlotte L Deijen, Gerbert L Vrijenhoek, Eva E Schaake, et al.
NMR in Biomedicine|July 6, 2018
Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancerEdzo M E Klawer, Petra J van Houdt, Floris J Pos, et al.
The Prostate|July 28, 2025
Efficacy of Treatments for T3bN0M0 Prostate Cancer Patients: A Systematic Review and Meta-AnalysisCasper Reijnen, Wilma D Heemsbergen, Kimberley E Wever, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Behavior of lipiodol markers during image guided radiotherapy of bladder cancerXiangfei Chai, Marcel van Herk, Jeroen B van de Kamer, et al.
Cancers|July 9, 2022
Specialist versus Primary Care Prostate Cancer Follow-Up: A Process Evaluation of a Randomized Controlled TrialBarbara M Wollersheim, Kristel M van Asselt, Floris J Pos, et al.
Clinical and Translational Radiation Oncology|January 7, 2025
Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancerChristian A M Jongen, Ben J M Heijmen, Wilco Schillemans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 2023
Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patientsMarie-Christina Jahreiß, Mischa Hoogeman, Katja Kh Aben, et al.
Pageof 9